Maker LogoSuper Survey Maker
Survey MakerSurvey TemplatesContactPrivacy & Security

Molecular Pathology and Targeted Therapy Quiz

In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?
HRD status
Response to platinum-based therapy
Previous Platinum-free interval
For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?
15%
25%
50%
Which is the molecular type of endometrial carcinoma, most likely associated with good prognosis?
P53 abnormal
Non specific molecular profile
Mismatch Repair Deficient
Pole mutated
{"name":"Molecular Pathology and Targeted Therapy Quiz", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?, For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?, Please enter your email address","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

More Quizzes

Phrasal verb (1)
10513
The Princess and the Pea
9452
Alphabet
100
Tulong Dunong Quiz by Denyz Del Villar 11-Goupil
1058
Nikolay Davydenko: Test Your Tennis IQ & Ace It
201035347
Free Spanish Speaking Countries & Capitals
201022337
Free Outsiders Book Test &
201026418
Challenge Yourself with a C1 Vocabulary Gap Fill
201031010
Ultimate Cars: Test Your Car Knowledge & Skills
201039358
Free: Which Ratio Describes the Tangent Function?
201021855
Free AZSCI Test Review
201021855
How Well Do We Know Each Other Questions? Take the!
201058576
Make your own Survey
- it's free to start.
Super Survey Logo
Powered by
Super Survey Maker | Super Templates Make your own Survey